Lercanidipine: Difference between revisions
No edit summary |
Kiran Singh (talk | contribs) No edit summary |
||
(2 intermediate revisions by one other user not shown) | |||
Line 25: | Line 25: | ||
}} | }} | ||
__NOTOC__ | __NOTOC__ | ||
{{SI}} | |||
{{CMG}} | {{CMG}} | ||
Line 32: | Line 33: | ||
It is sold under various commercial names including '''Zanidip'''. | It is sold under various commercial names including '''Zanidip'''. | ||
== | ==References== | ||
{{reflist|2}} | |||
==External Links== | ==External Links== | ||
* {{DiseasesDB|31597}} | * {{DiseasesDB|31597}} | ||
[[Category: Calcium channel blockers]] | [[Category:Calcium channel blockers]] | ||
[[Category: Cardiovascular Drugs]] | [[Category:Cardiovascular Drugs]] | ||
[[Category:Drug]] | [[Category:Drug]] |
Latest revision as of 14:18, 8 April 2015
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C36H41N3O6 |
Molar mass | 611.727 g/mol |
WikiDoc Resources for Lercanidipine |
Articles |
---|
Most recent articles on Lercanidipine Most cited articles on Lercanidipine |
Media |
Powerpoint slides on Lercanidipine |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Lercanidipine at Clinical Trials.gov Trial results on Lercanidipine Clinical Trials on Lercanidipine at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Lercanidipine NICE Guidance on Lercanidipine
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Lercanidipine Discussion groups on Lercanidipine Patient Handouts on Lercanidipine Directions to Hospitals Treating Lercanidipine Risk calculators and risk factors for Lercanidipine
|
Healthcare Provider Resources |
Causes & Risk Factors for Lercanidipine |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Lercanidipine is a calcium channel blocker of the dihydropyridine class.
It is sold under various commercial names including Zanidip.
References
External Links
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Calcium channel blockers
- Cardiovascular Drugs
- Drug